Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $941.91 ($95K) on 2024-02-01, disclosed to the SEC on 2024-02-05.
Scheduled sale ($95k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $939.53 | 1 | $940 | 1.0% |
| 2 | $941.91 | 6 | $6K | 5.9% |
| 3 | $942.50 | 5 | $5K | 4.9% |
| 4 | $943.54 | 3 | $3K | 3.0% |
| 5 | $944.66 | 1 | $945 | 1.0% |
| 6 | $947.37 | 3 |
| $3K |
| 3.0% |
| 7 | $948.77 | 1 | $949 | 1.0% |
| 8 | $949.48 | 10 | $9K | 10.0% |
| 9 | $950.01 | 2 | $2K | 2.0% |
| 10 | $951.40 | 3 | $3K | 3.0% |
| 11 | $953.18 | 3 | $3K | 3.0% |
| 12 | $954.52 | 5 | $5K | 5.0% |
| 13 | $955.35 | 10 | $10K | 10.0% |
| 14 | $956.21 | 7 | $7K | 7.0% |
| 15 | $957.75 | 3 | $3K | 3.0% |
| 16 | $958.65 | 5 | $5K | 5.0% |
| 17 | $959.68 | 8 | $8K | 8.0% |
| 18 | $960.52 | 10 | $10K | 10.1% |
| 19 | $961.37 | 4 | $4K | 4.0% |
| 20 | $962.49 | 6 | $6K | 6.1% |
| 21 | $963.73 | 4 | $4K | 4.0% |
| Total | $954.22 avg | 100 | $95K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |